Last year, IRadimed Corp generated 31.64M USD for its biggest-performing segment, MRI Compatible IV Infusion Pump Systems. The United States made the largest contribution, accounting for 70.56M USD last year. For the latest quarter, IRadimed Corp reported the revenue of 6.67M USD for the period ending 2026-06-30, which came from the top-performing segment, MRI Compatible Patient Vital Signs Monitoring Systems. United States contributed the highest revenue, at 16.72M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

MRI Compatible IV Infusion Pump Systems

MRI Compatible Patient Vital Signs Monitoring Systems

Disposables, services and other

Amortization of extended warranty agreements

Ferro Magnetic Detection Systems

FY2025

FY2024

FY2023

MRI Compatible IV Infusion Pump Systems

31.64M(37.75%)

26.60M(36.32%)

19.61M(29.91%)

MRI Compatible Patient Vital Signs Monitoring Systems

26.43M(31.53%)

24.41M(33.33%)

25.41M(38.76%)

Disposables, services and other

21.45M(25.60%)

19.07M(26.04%)

17.58M(26.81%)

Amortization of extended warranty agreements

2.38M(2.84%)

2.25M(3.07%)

2.01M(3.07%)

Ferro Magnetic Detection Systems

1.92M(2.29%)

909.62K(1.24%)

944.79K(1.44%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

70.56M(84.18%)

60.61M(82.75%)

52.53M(80.12%)

43.90M(82.36%)

33.46M(80.03%)

24.54M(77.36%)

30.93M(80.30%)

International

13.26M(15.82%)

12.64M(17.25%)

13.04M(19.88%)

9.40M(17.64%)

8.35M(19.97%)

7.18M(22.64%)

7.59M(19.70%)